Aberdeen Group’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
BTW
Aberdeen Group's ACLS Position: Q1 2025 in Review
Aberdeen Group sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 32,510 shares — an estimated $2.29M sold.
Aberdeen Group first reported a position in ACLS in Q2 2023 and held it in 7 quarters. The position peaked at $23.4M in Q4 2023. 306 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.
- Aberdeen Group reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
- Aberdeen Group sold 32,510 Axcelis shares in Q1 2025, an estimated $2.29M.
- Aberdeen Group first reported a position in Axcelis in Q2 2023 and held it in 7 quarters.
- Aberdeen Group's Axcelis position peaked at $23.4M in Q4 2023.
- 306 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.
Based on Aberdeen Group's 13F filing for Q1 2025, filed 13 May 2025.